<DOC>
	<DOCNO>NCT00478790</DOCNO>
	<brief_summary>The purpose study determine whether ologen ( OculusGen ) Collagen Matrix effective safe implant aid glaucoma surgery pterygium excision surgery .</brief_summary>
	<brief_title>Ologen ( Oculusgen ) -Glaucoma Pterygium Historical Control Study China Shanghai Sixth People 's Hospital</brief_title>
	<detailed_description>ologen ( OculusGen ) Collagen Matrix porous , scaffold matrix . It implant top scleral flap beneath conjunctiva Tenon 's capsule end trabeculectomy . The pore scaffold matrix range 20 200µm , size suitable fibroblast grow randomly , body matrix without cause scar . The space occupy collagen matrix scaffold create room development filtration bleb . Immediately implantation , collagen matrix absorb aqueous humor bring certain pressure press top scleral flap make dynamic balance aqueous system keep IOP right side . The collagen matrix bio-degraded within 90 day leave physiologic space filtration bleb facilitate control intraocular pressure ( IOP ) .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Pterygium</mesh_term>
	<criteria>Age 18 year Patient able cooperate study procedure able perform test reliably Patient willing sign inform consent Patient able willing complete postoperative followup requirement Glaucoma：one/both eye affect glaucoma Pterygium： patient pterygium Known allergic reaction collagen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Pterygium</keyword>
	<keyword>collagen matrix</keyword>
	<keyword>OculusGen</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>Anti scar</keyword>
	<keyword>pterygium recurrence</keyword>
	<keyword>tissue engineering</keyword>
	<keyword>ologen</keyword>
	<keyword>Aeon Astron</keyword>
</DOC>